- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More
| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| ACHV | Achieve Life Sciences Inc. | 1.64% | 2,751,032 | $17,964,239 | 2,751,032 | New | $6.53 | 13F |
| EDIT | Editas Medicine Inc | 1.05% | 3,555,250 | $11,519,010 | 3,555,250 | New | $3.24 | 13F |
| ODTX | Odyssey Therapeutics Inc | 0.98% | 575,000 | $10,758,250 | 575,000 | New | $18.71 | 13F |
| AURA | Aura Biosciences Inc | 0.76% | 1,166,667 | $8,283,336 | 1,166,667 | New | $7.1 | 13F |
| AVTX | Avalo Therapeutics Inc | 0.46% | 275,000 | $5,082,000 | 275,000 | New | $18.48 | 13F |
| VALN | Valneva SE | 0.36% | 763,199 | $3,991,531 | 763,199 | New | $5.23 | 13F |
| INM | InMed Pharmaceuticals Inc | 0.11% | 798,377 | $1,237,484 | 798,377 | New | $1.55 | 13F |